Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Chuanjian Suo"'
Autor:
Li Sun, Dongliang Zhang, Jiawen Liu, Xiang Gao, Chuanjian Suo, Shuang Fei, Zhengkai Huang, Zijie Wang, Hao Chen, Jun Tao, Zhijian Han, Xiaobing Ju, Zengjun Wang, Min Gu, Ruoyun Tan
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Background The assessment of left ventricular (LV) remodeling and its association with mineral and bone disorder (MBD) in kidney transplant recipients (KTRs) have not been systematically studied. We aimed to evaluate LV remodeling changes one year af
Externí odkaz:
https://doaj.org/article/4c6b661cb1684d37ad9bd55dbcc55d5b
Autor:
Li Sun, Jun Tao, Zhijian Han, Hao Chen, Zhengkai Huang, Zijie Wang, Shuang Fei, Chuanjian Suo, Xiaobing Ju, Ruoyun Tan, Min Gu
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Background Iguratimod has been shown to promote bone formation and inhibit bone resorption in rheumatoid arthritis patients. We aimed to explore its effect on bone metabolism and vascular calcification (VC) in kidney transplant recipients (KTRs).Meth
Externí odkaz:
https://doaj.org/article/77df26ea3d2045f0bd976e5650cf163b
Autor:
Yao Zhang, Yanhua Mou, Jianjian Zhang, Chuanjian Suo, Hai Zhou, Min Gu, Zengjun Wang, Ruoyun Tan
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Renal fibrosis is a common feature of chronic kidney disease (CKD), and can lead to the destruction of normal renal structure and loss of kidney function. Little progress has been made in reversing fibrosis in recent years. Ferroptosis is more immuno
Externí odkaz:
https://doaj.org/article/c7c78fd14d654c0fad156e2ff9c47272
Autor:
Zeping Gui, Chuanjian Suo, Jun Tao, Zijie Wang, Ming Zheng, Shuang Fei, Hao Chen, Li Sun, Zhijian Han, Xiaobing Ju, Hengcheng Zhang, Min Gu, Ruoyun Tan
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Chronic allograft dysfunction (CAD) is the major cause of late graft loss in long-term renal transplantation. In our previous study, we found that epithelial–mesenchymal transition (EMT) is a significant event in the progression of renal allograft
Externí odkaz:
https://doaj.org/article/60a21f7706e34998a0971ffee83514da
Autor:
Zeping Gui, Chuanjian Suo, Zijie Wang, Ming Zheng, Shuang Fei, Hao Chen, Li Sun, Zhijian Han, Jun Tao, Xiaobin Ju, Haiwei Yang, Min Gu, Ruoyun Tan
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Chronic renal graft dysfunction (CAD) is caused by multiple factors, including glomerular sclerosis, inflammation, interstitial fibrosis and tubular atrophy (IF/TA). However, the most prominent elements of CAD are IF/TA. Our studies have confirmed th
Externí odkaz:
https://doaj.org/article/330783fc508d46229642aa90efa4727e
Autor:
Hengcheng Zhang, Xiang Gao, Zeping Gui, Chuanjian Suo, Jun Tao, Zhijian Han, Xiaobin Ju, Ruoyun Tan, Min Gu, Zijie Wang
Publikováno v:
Translational Andrology and Urology. 12:375-383
Autor:
Shuang Fei, Zijie Wang, Hao Chen, Zeping Gui, Ming Zheng, Ruoyun Tan, Chuanjian Suo, Min Gu, Jiajun Zhou
Publikováno v:
Clinical Science. 135:53-69
Chronic allograft dysfunction is a major cause of late graft failure after kidney transplantation. One of the histological changes is interstitial fibrosis, which is associated with epithelial–mesenchymal transition. Bortezomib has been reported to
Autor:
Liang Geng, Ruoyun Tan, Jiayi Zhang, Hao Chen, Hengcheng Zhang, Chuanjian Suo, Jiajun Zhou, Zijie Wang, Hong Cheng, Yanhao Yang, Ming Gu
Publikováno v:
Journal of Cellular and Molecular Medicine
Allograft interstitial fibrosis was characterized by massive extracellular matrix deposition caused by activated fibroblasts and myofibroblasts. Epithelial‐mesenchymal transition (EMT) is recognized as an important source of myofibroblasts contribu
Autor:
Shuang Fei, Chunchun Zhao, Min Gu, Jun Tao, Zijie Wang, Zhen Xu, Ruoyun Tan, Zhijian Han, Chuanjian Suo
Publikováno v:
Annals of Transplantation
BACKGROUND The related mechanisms involved in allograft interstitial fibrosis and chronic allograft dysfunction (CAD), following renal transplant, remain largely unknown. Here, we explored the role of hepatocyte growth factor (HGF) treatment on the e
Autor:
Min Gu, Ruoyun Tan, Jun Tao, Zijie Wang, Zhijian Han, Hongliang Que, Zhengkai Huang, Xiaobin Ju, Chuanjian Suo
Publikováno v:
Oncotarget
// Zijie Wang 1, * , Hongliang Que 1, * , Chuanjian Suo 1, * , Zhijian Han 1 , Jun Tao 1 , Zhengkai Huang 1 , Xiaobin Ju 1 , Ruoyun Tan 1 and Min Gu 1 1 Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 21